Multipotent cells of monocytic origin improve damaged heart function

American Journal of Transplantation

Volumn 6, Issue 5 I, 2006, Pages 947-958

  Dresske, B ^a   El Mokhtari, N E ^a   Ungefroren, H ^a   Ruhnke, M ^a   Plate, V ^a   Janssen, D ^a   Siebert, R ^a   Reinecke, A ^a   Simon, R ^a   Fandrich, F ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Monocytes; Myocardial infarction; Stem cells

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICRODISSECTION; MONOCYTE; MORTALITY; MULTIPOTENT STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SRY GENE; Y CHROMOSOME; ANIMAL; CAPILLARY; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; ECHOCARDIOGRAPHY; GENETICS; HEART FUNCTION TEST; LEWIS RAT; MALE; PATHOLOGY; POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMALS; CAPILLARIES; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; MALE; MONOCYTES; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT; Y CHROMOSOME;

EID: 33745273872     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01289.x     Document Type: Article

References (40)

1. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98: 216-224.
2. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98.
3. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001; 121: 871-878.
4. Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 461-468.
5. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
6. Ruhnke M, Ungefroren H, Nussler A et al. Differentiation of in vitro modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005; 128: 1775-1786.
7. Ruhnke M, Nussler A, Ungefroren H et al. Human monocyte-derived neo-hepatocytes (NeoHep cells): A promising alternative to primary hepatocytes for autologous cell therapy. Transplantation 2005; 79(9): 1097-1103.
8. Friedman AD. Transcriptional regulation of granulocyte and monocyte development. Oncogene 2002; 21: 3377-3390.
9. Chang DH, Angelin-Duclos C, Calame K. BLIMP-1: Trigger for differentiation of myeloid lineage. Nat Immunol 2000; 1: 169-176.
10. Gyory I, Fejer G, Ghosh N, Seto E, Wright KL. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003; 170: 3125-3133.
11. Tamura T, Kong HJ, Tunyaplin C, Tsujimura H, Calame K, Ozato K. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. Blood 2003; 102: 4547-4554.
12. Meissner A, Min JY, Simon R. Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol 1998; 30: 2507-2518.
13. Hill JA, Karimi M, Kutschke W et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000; 101: 2863-2869.
14. Schiller NB, Acquatella H, Ports TA et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 1979; 60: 547-555.
15. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
16. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075-1082.
17. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 2003; 100: 2426-2431.
18. Kuwana M, Okazaki Y, Kodama H et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003; 74: 833-845.
19. Hass R, Gunji H, Datta R et al. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Cancer Res 1992; 52: 1445-1450.
20. Roussel MF. Regulation of cell cycle entry and G1 progression by CSF-1. Mol Reprod Dev 1997; 46: 11-18.
21. Mangi MH, Newland AC. Interleukin-3 in hematology and oncology: Current state of knowledge and future directions. Cytokines Cell Mol Ther 1999; 5: 87-95.
22. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. J Immunol 2003; 171: 142-151.
23. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494-501.
24. Forrester JS, Price MJ, Makkar RR. Stem cell repair of infarcted myocardium: An overview for clinicians. Circulation 2003; 108: 1139-1145.
25. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
26. Gupta P, Blazar BR, Gupta K, Verfaillie CM. Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma. Blood 1998; 91: 3724-3733.
27. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-280.
28. Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-933.
29. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144: 1113-1122.
30. Muller-Ehmsen J, Whittaker P, Kloner RA et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002; 34: 107-116.
31. Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999; 100: 193-202.
32. Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation 2003; 107: 935-938.
33. Torrente Y, Camirand G, Pisati F et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 2003; 162: 511-520.
34. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973-981.
35. Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637.
36. Liesveld JL, Rosell K, Panoskaltsis N, Belanger T, Harbol A, Abboud CN. Response of human CD34+ cells to CXC, CC, and CX3C chemokines: Implications for cell migration and activation. J Hematother Stem Cell Res 2001; 10: 643-655.
37. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21: 737-746.
38. Tambara K, Sakakibara Y, Sakaguchi G et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003; 108 (Suppl 1): II259-263.
39. Assmus B, Schachinger V, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
40. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.